http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105055422-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28908f42a3efe1ea914a0ca680268028 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-546 |
| filingDate | 2015-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11a5e63913a29e394e6c79e84e7cb22e |
| publicationDate | 2015-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105055422-A |
| titleOfInvention | Anti-infective medicinal cefazedone sodium sterile composition |
| abstract | The invention discloses an anti-infective medicinal cefazedone sodium composition, and belongs to the technical field of medicines. The composition consists of cefazedone sodium and sodium chloride; the cefazedone sodium is crystals; an X-ray powder diffraction pattern obtained by measuring the crystals by using Cu-K alpha rays is shown as figure 1; the main particle size of the crystals of the cefazedone sodium is 150 to 180 mu m, and the distribution width is 135 to 195 mu m. The new crystal form of the cefazedone sodium provided by the invention is different from the crystal form structure in the prior art; through experimental verification, people surprisingly find that powder-injection prepared by utilizing the new crystal form compound is high in mobility compared with the prior art; moreover, the content of impurities and the content of water are effectively reduced; the product is high in safety and high in stability. |
| priorityDate | 2015-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.